NP
VYNT

NorthRock Partners’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

NorthRock Partners’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,766
Closed -$11K – 356
2022
Q3 		$11K Hold
3,766
– – ﹤0.01% 299
2022
Q2 		$17K Hold
3,766
– – ﹤0.01% 302
2022
Q1 		$27K Hold
3,766
– – ﹤0.01% 334
2021
Q4 		$25K Hold
3,766
– – ﹤0.01% 333
2021
Q3 		$44K Hold
3,766
– – ﹤0.01% 278
2021
Q2 		$70K Buy
+3,766
New +$70.2K 0.01% 249

Other funds holding VYNT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
HF
HRT Financial New York $26B AUM 58.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return